The emerging treatment of the medication represents a significant development in the care of diabetes mellitus type 2. Distinct from existing therapies, tirzepatide targets dual pathways – glucagon-like peptide-1 https://tirzepatide-peptide258607.blogs-service.com/73153328/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment